Ab locks for improving the selectivity and safety of antibody drugs-Reference-Cited by-同舟云学术

Ab locks for improving the selectivity and safety of antibody drugs

Published:2020-06-25 Issue:1 Volume:27 Page:
ISSN:1423-0127
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Lin Wen-Wei,Lu Yun-Chi,Chuang Chih-Hung,Cheng Tian-Lu

Funder

Kaohsiung Medical University

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Academia Sinica

Changhua Christian Hospital

Ministry of Education

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry, medical,Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12929-020-00652-z.pdf

Reference198 articles.

1. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett. 1995;96(2):267–75.

2. Agrawal S, Statkevich P, Bajaj G, Feng Y, Saeger S, Desai DD, Park JS, Waxman IM, Roy A, Gupta M. Evaluation of immunogenicity of Nivolumab monotherapy and its clinical relevance in patients with metastatic solid tumors. J Clin Pharmacol. 2017;57(3):394–400.

3. Akcilar R, Namdar ND, Kocak FE, Bayat Z, Burhan H. ADAM 33 gene V4 C/G rs2787094 polymorphism in psoriasis. Bratisl Lek Listy. 2018;119(7):454–7.

4. Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma. 2007;48(7):1307–12.

5. Altrichter S, Boodstein N, Maurer M. Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients? Allergy. 2009;64(4):652–6.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancer;Heliyon;2024-09

2. Advancements and challenges in immunocytokines: A new arsenal against cancer;Acta Pharmaceutica Sinica B;2024-08

3. Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy;Acta Pharmaceutica Sinica B;2024-06

4. A Conditionally Activated Cytosol-Penetrating Antibody for TME-Dependent Intracellular Cargo Delivery;Antibodies;2024-05-02

5. Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity;Cell Reports Medicine;2024-05